Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00482495 · COMPLETED

Trial details

NCT number: NCT00482495
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2006-04-01
Primary completion: 2006-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.